Thursday, March 20, 2014 7:14:53 PM
I agree but the bigger question is, why does MNTA tank at every opportunity? It truly puzzles me. It would be hard for anyone with a ounce of common sense to not to see through this and conclude rather quickly that it was a trivial development. Instead MNTA get hammered and was down 9% at one point today.
One would think a company who has a more than reasonable shot to provide a generic for a 3 billion dollar branded drug in the next few months (and quite likely the ONLY one in the space for an extended period ) would have more respect from the market than that. Even the 3x related sell off (which was clearly a negative development in terms of initial uptake %) seemed overdone if one were to consider the bigger picture.
I honestly do not get the lack of respect for MNTA. What am I missing???? Perhaps the mEnox experience is the cause, fearing a repeat?? Honestly, I see more differences than similarities with mEnox to mCopx, but perhaps I am just being naive.
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
